AlzChem Group (Germany) Today
AlzChem Group is selling for under 20.40 as of the 29th of November 2024; that is 4.62 percent increase since the beginning of the trading day. The stock's last reported lowest price was 19.5. Equity ratings for AlzChem Group AG are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 10th of December 2022 and ending today, the 29th of November 2024. Click here to learn more.
Valuation
Check how we calculate scores
AlzChem Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. AlzChem Group's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding AlzChem Group or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| CEO Board | Andreas Niedermaier |
| Business Concentration | Specialty Chemicals (View all Sectors) |
AlzChem Group AG (ACT) is traded on XETRA Stock Exchange in Germany and employs 1,481 people. The company currently falls under 'Small-Cap' category with a current market capitalization of 189.03 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate AlzChem Group's market, we take the total number of its shares issued and multiply it by AlzChem Group's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. AlzChem Group AG has 10.14 M outstanding shares.
AlzChem Group generates positive cash flow from operations, but has no cash available
Check AlzChem Group Probability Of Bankruptcy
AlzChem Stock Against Markets
AlzChem Group Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with AlzChem Group stock to make a market-neutral strategy. Peer analysis of AlzChem Group could also be used in its relative valuation, which is a method of valuing AlzChem Group by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
AlzChem Group Corporate Executives
Elected by the shareholders, the AlzChem Group's board of directors comprises two types of representatives: AlzChem Group inside directors who are chosen from within the company, and outside directors, selected externally and held independent of AlzChem. The board's role is to monitor AlzChem Group's management team and ensure that shareholders' interests are well served. AlzChem Group's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, AlzChem Group's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Klaus Englmaier | Member COO | Profile |
Additional Tools for AlzChem Stock Analysis
When running AlzChem Group's price analysis, check to measure AlzChem Group's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy AlzChem Group is operating at the current time. Most of AlzChem Group's value examination focuses on studying past and present price action to predict the probability of AlzChem Group's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move AlzChem Group's price. Additionally, you may evaluate how the addition of AlzChem Group to your portfolios can decrease your overall portfolio volatility.